2nd Quarter - Report
LINCOLN POLICY GROUP for PFIZER
Firm
Client
Income
$80,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to drug pricing S.2543 - Prescription Drug Pricing Reduction Act of 2019 H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act Outreach regarding Rare Disease and Part-D copay assistance report language in FY2021 Labor HHS Appropriations cycle Outreach regarding drug supply concerns. Paycheck Protection Program and Healthcare Enhancement Act (CARES Act 2.0) (H.R. 266) Outreach on biosimilar shared savings.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAN ELLING | — |
| ROBERT HOLIFIELD | — |
| HANNAH LAMBIOTTE SMITH | — |
| BLANCHE LINCOLN | — |
| COLIN ROSKEY | — |
| THOMAS A SCULLY | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.